|
FADS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.119800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.072600E-01 |
| Normal-vs-Stage2 |
3.925400E-01 |
| Normal-vs-Stage3 |
1.812820E-01 |
| Normal-vs-Stage4 |
5.738600E-01 |
| Stage1-vs-Stage2 |
1.553760E-01 |
| Stage1-vs-Stage3 |
5.598400E-02 |
| Stage1-vs-Stage4 |
4.614400E-01 |
| Stage2-vs-Stage3 |
7.240400E-01 |
| Stage2-vs-Stage4 |
7.790200E-01 |
| Stage3-vs-Stage4 |
8.927400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.486600E-01 |
| Normal-vs-AfricanAmerican |
3.956600E-01 |
| Normal-vs-Asian |
9.735800E-01 |
| Caucasian-vs-AfricanAmerican |
2.494000E-01 |
| Caucasian-vs-Asian |
9.639400E-01 |
| AfricanAmerican-vs-Asian |
7.222000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.469800E-01 |
| Normal-vs-Female |
4.438100E-02 |
| Male-vs-Female |
1.475190E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.401000E-01 |
| Normal-vs-Extreme_Weight |
3.865800E-01 |
| Normal-vs-Obese |
8.177400E-01 |
| Normal-vs-Extreme_Obese |
1.251590E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.168000E-01 |
| Normal_Weight-vs-Obese |
8.545200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.398500E-02 |
| Extreme_Weight-vs-Obese |
3.385200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.561200E-01 |
| Obese-vs-Extreme_Obese |
7.669900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.698400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.844200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.241200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.697600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.243200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.283000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.038400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.299500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.770500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.471800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.013900E-02 |
| Normal-VS-Type2 PRCC |
2.298000E-01 |
| Normal-VS-KIRP CIMP |
1.14310000021156E-07 |
| Normal-VS-Unclassified PRCC |
1.605550E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.314130E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.18320000000549E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
1.583380E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.46060002665416E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
1.301190E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.1229999996587E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.414200E-01 |
| Normal-vs-N1 |
3.028800E-01 |
| Normal-vs-N2 |
7.962000E-01 |
| N0-vs-N1 |
3.315600E-01 |
| N0-vs-N2 |
7.282400E-01 |
| N1-vs-N2 |
8.202400E-01 |
|
|
